Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer
Roy S Herbst, S Gail Eckhardt, Razelle Kurzrock, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C Ong, Adrian M Jubb, Peter M Haverty, et al.
The Journal of Pathology
|
May 21, 2011
Notch3 signalling promotes tumour growth in colorectal cancer
Valentina Serafin, Luca Persano, Lidia Moserle, et al.
Cancer Research
|
September 18, 2012
p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model
Hoi Yee Chow, Adrian M Jubb, Jennifer N Koch, et al.
Journal of the National Cancer Institute
|
March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma
Christy C Ong, Adrian M Jubb, Diana Jakubiak, et al.
Plos One
|
March 8, 2013
High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck
David S Shames, Juliet Carbon, Kim Walter, et al.
The Journal of Experimental Medicine
|
October 30, 2013
Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration
Christine D Pozniak, Arundhati Sengupta Ghosh, Alvin Gogineni, et al.
The Journal of Pathology
|
May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models
Mallika Singh, Suzana S Couto, William F Forrest, et al.
The Journal of Pathology
|
July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Wei Zhou, Adrian M Jubb, Karen Lyle, et al.
The Journal of Clinical Investigation
|
August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy
Leisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 12, 2010
Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer
Roy S Herbst, S Gail Eckhardt, Razelle Kurzrock, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2011
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C Ong, Adrian M Jubb, Peter M Haverty, et al.
The Journal of Pathology
|
May 21, 2011
Notch3 signalling promotes tumour growth in colorectal cancer
Valentina Serafin, Luca Persano, Lidia Moserle, et al.
Cancer Research
|
September 18, 2012
p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model
Hoi Yee Chow, Adrian M Jubb, Jennifer N Koch, et al.
Journal of the National Cancer Institute
|
March 29, 2013
P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma
Christy C Ong, Adrian M Jubb, Diana Jakubiak, et al.
Plos One
|
March 8, 2013
High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck
David S Shames, Juliet Carbon, Kim Walter, et al.
The Journal of Experimental Medicine
|
October 30, 2013
Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration
Christine D Pozniak, Arundhati Sengupta Ghosh, Alvin Gogineni, et al.
The Journal of Pathology
|
May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models
Mallika Singh, Suzana S Couto, William F Forrest, et al.
The Journal of Pathology
|
July 31, 2014
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Wei Zhou, Adrian M Jubb, Karen Lyle, et al.
The Journal of Clinical Investigation
|
August 16, 2013
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy
Leisa Johnson, Mahrukh Huseni, Tanya Smyczek, et al.
Page
of 5